Ocular Therapeutix Inc. (OCUL) |
|
8.25 -0.08 (-0.96%)
|
07-01 16:00 |
|
Open: |
8.3 |
Pre. Close: |
8.33 |
|
High:
|
8.65 |
Low:
|
7.85 |
|
Volume:
|
915,210 |
Market Cap:
|
518M |
|
|
|
|
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, a hydrogel ophthalmic wound sealant to seal corneal incisions following cataract surgery. Its lead product candidate is DEXTENZA (dexamethasone ophthalmic insert), which has completed two Phase III clinical trials for the treatment of post-surgical ocular pain and inflammation, and allergic conjunctivitis; and DEXTENZA, which is in Phase III clinical trials for the treatment of dry eye diseases. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
8.66 - 8.706 |
8.706 - 8.745 |
|
Low:
|
7.75 - 7.798 |
7.798 - 7.838 |
|
Close:
|
8.168 - 8.253 |
8.253 - 8.325 |
|
Technical analysis |
as of: 2020-07-01 4:35:38 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 10.79 One year: 12.61 |
| Support: |
Support1: 7.61 Support2: 6.61 |
| Resistance: |
Resistance1: 9.24 Resistance2: 10.79 |
| Pivot: |
8.43  |
| Moving Average: |
MA(5): 8.36 MA(20): 8.17
MA(100): 6.14 MA(250): 4.89 |
| MACD: |
MACD(12,26): 0.42 Signal(9): 0.51 |
| Stochastic oscillator: |
%K(14,3): 57.06 %D(3): 58.80 |
| RSI: |
RSI(14): 56.02 |
| 52-week: |
High: 9.24 Low: 2.46 Change(%): 60.2 |
| Average Vol(K): |
3-Month: 96922 10-Days: 104073 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.OCUL has closed above bottom band by 41.6%. Bollinger Bands are 6.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 01 Jul 2020
Riding the Trend or Protecting Profits: Ocular Therapeutix, Inc. (OCUL) - The News Heater
Fri, 26 Jun 2020
Breaking News: Ocular Therapeutix, Inc. (OCUL) On A Technical Move, Learn Why - Invest Million
Fri, 19 Jun 2020
Is Now the Time to Invest in Ocular Therapeutix Inc. (NASDAQ:OCUL)? - The Oracle Dispatch
Thu, 18 Jun 2020
Is a Correction Looming Ahead? Ocular Therapeutix, Inc. (OCUL) - The News Heater
Thu, 18 Jun 2020
Is Ocular Therapeutix Inc (OCUL) a Winner in the Biotechnology Industry? - InvestorsObserver
Mon, 15 Jun 2020
Ocular Therapeutix™ to Hold Virtual 2020 Annual Meeting Of Stockholders - Business Wire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Global Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
63 |
| Shares Float (M) |
47 |
|
% Held by Insiders
|
9.89 |
|
% Held by Institutions
|
50.83 |
|
Shares Short (K)
|
5,620 |
|
Shares Short P. Month (K)
|
5,490 |
Stock Financials |
|
EPS
|
-1.900 |
|
EPS Est This Year
|
-2.290 |
|
EPS Est Next Year
|
-2.110 |
|
Book Value (p.s.)
|
-0.200 |
|
Profit Margin
|
|
|
Operating Margin
|
-1304.51 |
|
Return on Assets (ttm)
|
-59.3 |
|
Return on Equity (ttm)
|
-1211.0 |
|
Qtrly Rev. Growth
|
430.3 |
|
Gross Profit (p.s.)
|
-0.624 |
|
Sales Per Share
|
0.101 |
|
EBITDA (p.s.)
|
-1.276 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-77 |
|
Levered Free Cash Flow (M)
|
-51 |
Stock Valuations |
|
PE Ratio
|
-4.34 |
|
PEG Ratio
|
|
|
Price to Book value
|
-41.25 |
|
Price to Sales
|
81.68 |
|
Price to Cash Flow
|
-6.72 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
